VRDN
Viridian Therapeutics, Inc. · Healthcare
Chief Exec Officer Jonathan Violin sold $568K of Viridian Therapeutics, Inc.
Sold$567,636
$18.92Price
30,000Shares
−5%Stake
What VRDN did after the filing
- The stock from Tue, Apr 5 close, $18.91
- −24.9%
- S&P 500, same days
- −13.1%
Measured over 30 trading days, to the May 18 close.
Traded Fri, Apr 1. Filed Tue, Apr 5, 2:09 PM ET, during the session. Returns use the Apr 5 close and the May 18 close. Not investment advice.